HCM
$15.28
Revenue | $138.84Mn |
Net Profits | $227.48Mn |
Net Profit Margins | 163.84% |
Hutchison China Meditech Limited’s revenue fell -9.16% since last year same period to $138.84Mn in the Q2 2025. On a quarterly growth basis, Hutchison China Meditech Limited has generated 0% jump in its revenue since last 3-months.
Hutchison China Meditech Limited’s net profit jumped 1663.32% since last year same period to $227.48Mn in the Q2 2025. On a quarterly growth basis, Hutchison China Meditech Limited has generated 0% jump in its net profits since last 3-months.
Hutchison China Meditech Limited’s net profit margin jumped 1841.15% since last year same period to 163.84% in the Q2 2025. On a quarterly growth basis, Hutchison China Meditech Limited has generated 0% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0 |
EPS Estimate Current Year | 0 |
Hutchison China Meditech Limited’s earning per share (EPS) estimates for the current quarter stand at 0 - a NaN% jump from last quarter’s estimates.
Hutchison China Meditech Limited’s earning per share (EPS) estimates for the current year stand at 0.
Earning Per Share (EPS) | 0 |
Hutchison China Meditech Limited’s earning per share (EPS) jumped NaN% since last year same period to 0 in the Q3 2025. This indicates that the Hutchison China Meditech Limited has generated NaN% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-03-31 | 0 | 0 | NaN% |
2025-11-14 | 0 | 0 | NaN% |
2025-08-07 | 0 | 0.52 | +Inf% |